Compounds > alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol
Page last updated: 2024-09-02

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and perphenazine

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with perphenazine in 1 studies

Compound Research Comparison

Studies
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Trials
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Recent Studies (post-2010)
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Studies
(perphenazine)		Trials
(perphenazine)		Recent Studies (post-2010) (perphenazine)
90121,666243128

Protein Interaction Comparison

ProteinTaxonomyalpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (IC50)perphenazine (IC50)
ubiquitin-conjugating enzyme E2 NHomo sapiens (human)14.79
Aldehyde oxidase 1Mus musculus (house mouse)6.1
Retinal dehydrogenase 1Homo sapiens (human)0.5242
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)4.216
D(2) dopamine receptorHomo sapiens (human)0.0003
Pleiotropic ABC efflux transporter of multiple drugsSaccharomyces cerevisiae S288C1.4
Aldehyde oxidaseHomo sapiens (human)0.033
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)4.216
Aldehyde oxidase 1Macaca fascicularis (crab-eating macaque)3.6
Nuclear receptor subfamily 3 group C member 3 Bos taurus (cattle)4.216
Aldehyde oxidase 1 Rattus norvegicus (Norway rat)0.74

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akiyama, K; Kuroda, S; Okumura, K; Ujike, H1

Other Studies

1 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and perphenazine

ArticleYear
BMY-14802 reversed the sigma receptor agonist-induced neck dystonia in rats.
    Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:10

    Topics: Animals; Antipsychotic Agents; Dibenzothiepins; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dystonia; Guanidines; Haloperidol; Male; Microinjections; Nerve Tissue Proteins; Perphenazine; Piperidines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, sigma; Red Nucleus; Sulpiride; Torticollis

1996